Investor.precisionbiosciences.com

Press Releases

Press Releases

PBGENE-HBV is the first-ever investigational in vivo gene editing therapy cleared to enter clinical trials for the treatment of chronic hepatitis B in the ...

Domein: investor.precisionbiosciences.com Bekijk meer